Cardio Diagnostics Holdings, Inc.
Cardio Diagnostics Holdings, Inc. (CDIO) Revenue
Annual & quarterly revenue history · segment & region breakdown
CDIO · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsCardio Diagnostics Holdings, Inc. trailing twelve-month (TTM) revenue is $0.00B, a decrease of 57.51% year-over-year from $0.00B in FY2025.
Revenue trend
2025 – 2020 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.00B | -$0.00B | -57.51% |
| 2024-12-31 | $0.00B | +$0.00B | +104.45% |
| 2023-12-31 | $0.00B | +$0.00B | +1696.32% |
| 2022-12-31 | $0.00B | +$0.00B | +5.44% |
| 2021-12-31 | $0.00B | +$0.00B | — |
| 2020-12-31 | $0.00B | — | — |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Cardio Diagnostics Holdings, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Cardio Diagnostics Holdings, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Cardio Diagnostics Holdings, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
CDIO revenue · 4 questionsCDIO's trailing twelve-month (TTM) revenue is $0.00B. That is a decrease of 57.51% year-over-year from $0.00B in FY2025.
▸ Source: FMP · Cardio Diagnostics Holdings, Inc. SEC filings · GAAP · Cardio Diagnostics Holdings, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026